Total Payments
$3,407
2024 Payments
$255.77
Companies
17
Transactions
136
Medicare Patients
6,630
Medicare Billing
$322,334
Payment Breakdown by Category
Food & Beverage$2,474 (72.6%)
Travel$915.24 (26.9%)
Education$18.18 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,474 | 131 | 72.6% |
| Travel and Lodging | $915.24 | 4 | 26.9% |
| Education | $18.18 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,150 | 53 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $231.91 | 32 | $0 (2021) |
| ABIOMED | $133.61 | 5 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $118.58 | 8 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $97.62 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $96.00 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $92.03 | 6 | $0 (2024) |
| PFIZER INC. | $90.32 | 4 | $0 (2023) |
| Amgen Inc. | $84.85 | 5 | $0 (2024) |
| Abbott Laboratories | $82.47 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.77 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($62.65) |
| 2023 | $264.46 | 12 | AstraZeneca Pharmaceuticals LP ($36.72) |
| 2022 | $103.34 | 6 | Boston Scientific Corporation ($35.26) |
| 2021 | $329.80 | 19 | BOSTON SCIENTIFIC CORPORATION ($103.16) |
| 2020 | $137.46 | 10 | Boston Scientific Corporation ($88.97) |
| 2019 | $278.22 | 17 | Janssen Pharmaceuticals, Inc ($57.08) |
| 2018 | $532.18 | 31 | BOSTON SCIENTIFIC CORPORATION ($292.35) |
| 2017 | $1,506 | 29 | BOSTON SCIENTIFIC CORPORATION ($1,484) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Boston Scientific Corporation | Comet (Device) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: Comet_IC | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $41.06 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardiology | ||||||
| 02/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 01/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: RESPIRATORY | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Respiratory | ||||||
| 11/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Respiratory | ||||||
| 11/21/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Respiratory | ||||||
| 10/26/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Pulmonology | ||||||
| 08/30/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Inflammation | ||||||
| 08/17/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $29.23 | General |
| Category: Medical Device | ||||||
| 06/08/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: VACCINES | ||||||
| 05/03/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Education | In-kind items and services | $18.18 | General |
| Category: Cardiovascular | ||||||
| 03/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiology | ||||||
| 12/08/2022 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 896 | 1,031 | $107,216 | $32,413 |
| 2022 | 19 | 1,276 | 1,529 | $236,471 | $63,531 |
| 2021 | 21 | 1,883 | 2,174 | $412,019 | $92,913 |
| 2020 | 22 | 2,575 | 2,928 | $589,328 | $133,477 |
Total Patients
6,630
Total Services
7,662
Medicare Billing
$322,334
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 151 | 202 | $36,720 | $12,435 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 116 | 135 | $16,455 | $6,083 | 37.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 201 | 222 | $13,098 | $5,362 | 40.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 103 | 106 | $14,416 | $5,181 | 35.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2023 | 64 | 92 | $9,476 | $1,175 | 12.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 197 | 205 | $9,635 | $1,158 | 12.0% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2023 | 15 | 20 | $3,060 | $449.92 | 14.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 16 | 16 | $1,248 | $274.44 | 22.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 21 | 21 | $2,520 | $183.30 | 7.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $588.00 | $111.18 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 242 | 357 | $64,775 | $25,582 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 191 | 205 | $27,880 | $10,925 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 141 | 169 | $20,241 | $8,325 | 41.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 180 | 201 | $12,057 | $5,207 | 43.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 17 | 17 | $52,972 | $3,061 | 5.8% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Facility | 2022 | 89 | 123 | $12,669 | $1,958 | 15.5% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2022 | 89 | 100 | $12,000 | $1,264 | 10.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 15 | $3,360 | $1,177 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,344 | $1,091 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 16 | $2,496 | $874.91 | 35.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 125 | 136 | $6,392 | $789.50 | 12.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2022 | 36 | 36 | $2,808 | $746.82 | 26.6% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Facility | 2022 | 17 | 25 | $3,825 | $675.52 | 17.7% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2022 | 11 | 11 | $4,818 | $597.96 | 12.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 52 | 52 | $2,548 | $503.07 | 19.7% |
About Dr. John Best, MD
Dr. John Best, MD is a Cardiovascular Disease healthcare provider based in Bolivar, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154373462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Best, MD has received a total of $3,407 in payments from pharmaceutical and medical device companies, with $255.77 received in 2024. These payments were reported across 136 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,474).
As a Medicare-enrolled provider, Best has provided services to 6,630 Medicare beneficiaries, totaling 7,662 services with total Medicare billing of $322,334. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Bolivar, MO
- Active Since 05/16/2006
- Last Updated 12/29/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1154373462
Products in Payments
- GENERAL - THERAPIES (Device) $1,249
- LifeVest (Device) $231.91
- GENERAL THERAPIES (Device) $138.46
- Impella (Device) $133.61
- XARELTO (Drug) $118.58
- SQ-RX PULSE GENERATOR (Device) $115.96
- GENERAL - BRADY (Device) $95.41
- ENTRESTO (Drug) $92.03
- RESONATE (Device) $88.69
- HeartMate (Device) $82.47
- VERQUVO (Drug) $79.68
- LUX-Dx Insertable Cardiac Monitor (Device) $67.15
- OFEV (Drug) $62.65
- Repatha (Biological) $61.81
- FASENRA (Biological) $59.48
- VIGILANT (Device) $39.29
- BREZTRI (Drug) $38.14
- LUX DX (Device) $36.83
- CHANTIX (Drug) $34.82
- SPIRIVA RESPIMAT (Drug) $33.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.